Satellos Bioscience Inc. Common Stock (MSLE)

Satellos Bioscience Inc. Common Stock (MSLE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $145M; returns 1 day -3.1%, 1 week -0.6%.

Satellos Bioscience Inc. (MSLE) is a clinical-stage regenerative medicine company focused on developing small molecule therapeutics to restore muscle repair and regeneration in patients with degenerative muscle diseases. As of February 2026, the company is pre-revenue, operating primarily as a research and development entity with significant net losses.

Groups MSLE belongs to

• Recent Reverse Splits
• Recent IPOs
• Canada Companies
• Clinical Stage
• Biotechnology
• Regenerative Medicine
• Clinical Stage Biotech
• Biopharmaceutical
• Duchenne Muscular Dystrophy
• Healthcare Innovation
• R&D
• Life Sciences
• Healthcare

MSLE financial model: income statement, cash flow and balance sheet